Nature genetics · 2025
Population-scale gene-based analysis of whole-genome sequencing provides insights into metabolic health.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Yajie, Lockhart Sam, Liu Jimmy, Li Xihao, Cortes Adrian, Hua Xing, Gardner Eugene J, Kentistou Katherine A, Cañadas-Garre Marisa, Fabian Laurie, Ho Karen, Timpson Nicholas, Lo Yancy, Davitte Jonathan, Savage David B, Buser-Doepner Carolyn, Ong Ken K, Zhang Haoyu, Scott Robert, O'Rahilly Stephen, Perry John R B
Аннотация
In addition to its coverage of the noncoding genome, whole-genome sequencing (WGS) may better capture the coding genome than exome sequencing. Here we sought to exploit this and identify new rare, protein-coding variants associated with metabolic health in WGS data (n = 708,956) from the UK Biobank and All of Us studies. Identified genes highlight new biological mechanisms, including protein-truncating variants (PTVs) in the DNA double-strand break repair gene RIF1 that have a substantial effect on body mass index (2.66 kg m-2, s.e. 0.43, P = 3.7 × 10-10). UBR3 is an intriguing example where PTVs independently increase body mass index and type 2 diabetes risk. Furthermore, PTVs in IRS2 have a substantial effect on type 2 diabetes (odds ratio 6.4 (3.7-11.3), P = 9.9 × 10-14, 34% case prevalence among carriers) and were also associated with chronic kidney disease independent of diabetes status, suggesting an important role for IRS2 in maintaining renal health. Our study demonstrates that large-scale WGS provides new mechanistic insights into human metabolic phenotypes through improved capture of coding sequences.